Patents by Inventor Gregory Zarbis-Papastoitsis

Gregory Zarbis-Papastoitsis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purified antibody composition
    Patent number: 8895009
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: November 25, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED PROTEINS
    Publication number: 20140341843
    Abstract: The present invention provides methods and compositions for the preparation and delivery of chimeric cytokine proteins, including cell cultures, methods of purification and purified compositions.
    Type: Application
    Filed: July 27, 2012
    Publication date: November 20, 2014
    Applicant: ELEVEN BIOTHERAPEUTICS, INC.
    Inventors: Thomas M. Barnes, Jinzhao Hou, Gregory Zarbis-Papastoitsis, Emily Belcher Schirmer, Gary L. McNeil, Kathryn Golden
  • Purified antibody composition
    Patent number: 8883156
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: November 11, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY
    Publication number: 20140308239
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Application
    Filed: March 13, 2014
    Publication date: October 16, 2014
    Applicant: ELEVEN BIOTHERAPEUTICS, INC.
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20130323261
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: August 2, 2013
    Publication date: December 5, 2013
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20130309242
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: August 1, 2013
    Publication date: November 21, 2013
    Applicant: ABBVIE BIOTECHNOLOGY LTD.
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20130280267
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: June 26, 2013
    Publication date: October 24, 2013
    Applicant: ABBVIE, INC.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20130273059
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: June 26, 2013
    Publication date: October 17, 2013
    Applicant: ABBVIE, INC.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20130028903
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: June 25, 2012
    Publication date: January 31, 2013
    Inventors: MIN WAN, GEORGE AVGERINOS, GREGORY ZARBIS-PAPASTOITSIS
  • Purified antibody composition
    Patent number: 8231876
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: July 31, 2012
    Assignee: Abbott Biotechnology Ltd.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • ANTIBODY PURIFICATION
    Publication number: 20110002935
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: September 15, 2010
    Publication date: January 6, 2011
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Antibody purification
    Patent number: 7863426
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: January 4, 2011
    Assignee: Abbott Biotechnology Ltd.
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Antibody purification
    Publication number: 20070292442
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: April 4, 2007
    Publication date: December 20, 2007
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis